TATVA CHINTAN PHARMA CHEM
Back to All Ratios
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 14.27 | 23.92 | 24.83 | 46.95 | 29.37 |
What is the latest Cash Earnings per Share (CEPS) ratio of TATVA CHINTAN PHARMA CHEM ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 14.27 |
| Mar2024 | 23.92 |
| Mar2023 | 24.83 |
| Mar2022 | 46.95 |
| Mar2021 | 29.37 |
How is Cash Earnings per Share (CEPS) of TATVA CHINTAN PHARMA CHEM Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 14.27 | -40.34 | |
| Mar2024 | 23.92 | -3.66 | |
| Mar2023 | 24.83 | -47.11 | |
| Mar2022 | 46.95 | 59.86 | |
| Mar2021 | 29.37 | - | |
Other Financial Ratios of TATVA CHINTAN PHARMA CHEM
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹3,070.1 Cr | -1.6% | 5.3% | 63.4% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹157,015.0 Cr | 6.7% | 16.6% | 25.4% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹149,252.0 Cr | 2.1% | 10.3% | -3.5% | Stock Analytics | |
| SRF | ₹79,698.3 Cr | -3.9% | 7.6% | -9.4% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹40,803.2 Cr | -0.6% | 9.8% | -4.4% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹38,128.0 Cr | -1.7% | 24.9% | 2.6% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | -1.6% |
5.3% |
63.4% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses